Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > BS analyst forcasts

<< Previous

Bullboard Posts

Next >>

Comment by Sanderzon Apr 24, 2018 9:20am

71 Views

Post# 27931053

RE:BS analyst forcasts

pdesj2000 wrote: I think what bothers me the most about this whole dilution process is that after everything
that happened, most analysts still maintain that this is a strong buy. After looking at their firecasts
over the last 2-3 years, no wonder people are losing money. They have been totally off since the beginning.

I agree, Analysts' target prices don't mean anything! Just because they give a target price does not mean it WILL be that price. I can give this ANY target price I want, even if it's within reason, does that mean it will happen? Nope. I've said this many times before, I've yet to see any "target price" actually happen. I'm sure it happens once in a while, but more often than not the target price is never reached.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project